The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Antonio Tursi

Gastroenterology Service

ASL BAT

Andria (BT)

Italy

[email]@tiscali.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Gastroenterology Service, ASL BAT, Andria (BT), Italy. 2009 - 2012
  • ASL BAT, Andria, Italy. 2011
  • "Lorenzo Bonomo" Hospital, Andria, Italy. 2010
  • Division of Gastroenterology, "Michele Sarcone" Hospital, Terlizzi, Italy. 2010
  • Digestive Endoscopy Unit, 'Lorenzo Bonomo' Hospital, Andria (BA), Italy. 2002 - 2010

References

  1. Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Inchingolo, C.D., Nenna, R., Picchio, M., Giorgio, F., Ierardi, E. Neurogastroenterol. Motil. (2012) [Pubmed]
  2. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter Pylori infection. Tursi, A., Picchio, M., Elisei, W. J. Gastrointestin. Liver. Dis (2012) [Pubmed]
  3. Segmental colitis associated with diverticulosis: a 5-year follow-up. Tursi, A., Elisei, W., Giorgetti, G.M., Inchingolo, C.D., Nenna, R., Picchio, M., Brandimarte, G. Int. J. Colorectal. Dis (2012) [Pubmed]
  4. Tumour Necrosis Factor-alpha expression in segmental colitis associated with diverticulosis down-regulates after treatment. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Inchingolo, C.D., Nenna, R., Ierardi, E. J. Gastrointestin. Liver. Dis (2011) [Pubmed]
  5. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis. Tursi, A., Elisei, W., Giorgetti, G., Aiello, F., Brandimarte, G. Minerva. Gastroenterol. Dietol (2011) [Pubmed]
  6. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Tursi, A., Elisei, W., Giorgetti, G.M., Aiello, F., Brandimarte, G. Aliment. Pharmacol. Ther. (2011) [Pubmed]
  7. Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis is related to the severity of the endoscopic damage. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Inchingolo, C.D., Nenna, R., Ierardi, E. Dig. Liver. Dis (2011) [Pubmed]
  8. Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Aiello, F. J. Clin. Gastroenterol. (2010) [Pubmed]
  9. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G.M., Forti, G., Morini, S., Hassan, C., Pistoia, M.A., Modeo, M.E., Rodino', S., D'Amico, T., Sebkova, L., Sacca', N., Di Giulio, E., Luzza, F., Imeneo, M., Larussa, T., Di Rosa, S., Annese, V., Danese, S., Gasbarrini, A. Am. J. Gastroenterol. (2010) [Pubmed]
  10. Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G., Penna, A., Castrignano, V. Eur. Rev. Med. Pharmacol. Sci (2010) [Pubmed]
  11. Prevalence of celiac disease and symptoms in relatives of patients with celiac disease. Tursi, A., Elisei, W., Giorgetti, G.M., Gaspardone, A., Lecca, P.G., Di Cesare, L., Brandimarte, G. Eur. Rev. Med. Pharmacol. Sci (2010) [Pubmed]
  12. The endoscopic spectrum of segmental colitis associated with diverticulosis. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Lecca, P.G., Di Cesare, L., Inchingolo, C.D., Aiello, F. Colorectal. Dis (2010) [Pubmed]
  13. Crohn's appendicitis. Tursi, A., Penna, A. Endoscopy (2010) [Pubmed]
  14. Review article: the current and evolving treatment of colonic diverticular disease. Tursi, A., Papagrigoriadis, S. Aliment. Pharmacol. Ther. (2009) [Pubmed]
  15. Balsalazide in treating colonic diseases. Tursi, A. Expert. Opin. Drug. Metab. Toxicol (2009) [Pubmed]
  16. Complications in celiac disease under gluten-free diet. Tursi, A., Elisei, W., Giorgetti, G.M., Brandimarte, G., Aiello, F. Dig. Dis. Sci. (2009) [Pubmed]
  17. Faecal calprotectin in colonic diverticular disease: a case-control study. Tursi, A., Brandimarte, G., Elisei, W., Giorgetti, G.M., Inchingolo, C.D., Aiello, F. Int. J. Colorectal. Dis (2009) [Pubmed]
  18. Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W. Hepatogastroenterology (2008) [Pubmed]
  19. The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Tursi, A., Brandimarte, G., Giorgetti, G., Elisei, W., Maiorano, M., Aiello, F. Dig. Dis. Sci. (2008) [Pubmed]
  20. Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon. Tursi, A. J. Clin. Gastroenterol. (2008) [Pubmed]
  21. Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease. Tursi, A., Brandimarte, G., Elisei, W., Giorgetti, G.M., Inchingolo, C.D., Aiello, F. Dig. Liver. Dis (2008) [Pubmed]
  22. Effect of gluten-free diet on pregnancy outcome in celiac disease patients with recurrent miscarriages. Tursi, A., Giorgetti, G., Brandimarte, G., Elisei, W. Dig. Dis. Sci. (2008) [Pubmed]
  23. Assessment and grading of mucosal inflammation in colonic diverticular disease. Tursi, A., Brandimarte, G., Elisei, W., Giorgetti, G.M., Inchingolo, C.D., Danese, S., Aiello, F. J. Clin. Gastroenterol. (2008) [Pubmed]
  24. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W. Dig. Dis. Sci. (2007) [Pubmed]
  25. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W., Aiello, F. Int. J. Colorectal. Dis (2007) [Pubmed]
  26. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Tursi, A., Elisei, W., Brandimarte, G., Giorgetti, G.M., Modeo, M.E., Aiello, F. Med. Sci. Monit. (2007) [Pubmed]
  27. Synchronous gastric and colonic MALT-lymphoma in coeliac disease: a long-term follow-up on gluten-free diet. Tursi, A., Inchingolo, C.D. Dig. Liver. Dis (2007) [Pubmed]
  28. New physiopathological and therapeutic approaches to diverticular disease of the colon. Tursi, A. Expert. Opin. Pharmacother (2007) [Pubmed]
  29. Gastric outlet obstruction due to gastroduodenal eosinophilic gastroenteritis. Tursi, A., Rella, G., Inchingolo, C.D., Maiorano, M. Endoscopy (2007) [Pubmed]
  30. Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W., Inchingolo, C.D., Monardo, E., Aiello, F. Endoscopy (2006) [Pubmed]
  31. Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W. Dig. Dis. Sci. (2006) [Pubmed]
  32. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W. J. Clin. Gastroenterol. (2006) [Pubmed]
  33. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. Tursi, A., Giorgetti, G.M., Brandimarte, G., Elisei, W., Aiello, F. Med. Sci. Monit. (2006) [Pubmed]
  34. Crohn's disease and celiac disease: association or epiphenomenon?. Tursi, A., Giorgetti, G.M., Brandimarte, G., Elisei, W. Eur. Rev. Med. Pharmacol. Sci (2006) [Pubmed]
  35. Peripheral neurological disturbances, autonomic dysfunction, and antineuronal antibodies in adult celiac disease before and after a gluten-free diet. Tursi, A., Giorgetti, G.M., Iani, C., Arciprete, F., Brandimarte, G., Capria, A., Fontana, L. Dig. Dis. Sci. (2006) [Pubmed]
  36. Mesalazine for diverticular disease of the colon--a new role for an old drug. Tursi, A. Expert. Opin. Pharmacother (2005) [Pubmed]
  37. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. Tursi, A., Brandimarte, G., Giorgetti, G.M., Elisei, W. World J. Gastroenterol. (2005) [Pubmed]
  38. High prevalence of celiac disease among patients affected by Crohn's disease. Tursi, A., Giorgetti, G.M., Brandimarte, G., Elisei, W. Inflamm. Bowel Dis. (2005) [Pubmed]
  39. Acute diverticulitis of the colon--current medical therapeutic management. Tursi, A. Expert. Opin. Pharmacother (2004) [Pubmed]
  40. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. Tursi, A., Brandimarte, G., Torello, M. J. Clin. Gastroenterol. (2004) [Pubmed]
  41. Gastrointestinal motility disturbances in celiac disease. Tursi, A. J. Clin. Gastroenterol. (2004) [Pubmed]
  42. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Tursi, A., Brandimarte, G., Giorgetti, G.M., Forti, G., Modeo, M.E., Gigliobianco, A. Med. Sci. Monit. (2004) [Pubmed]
  43. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Tursi, A., Brandimarte, G., Giorgetti, G.M., Modeo, M.E. Med. Sci. Monit. (2004) [Pubmed]
  44. Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy. Tursi, A., Brandimarte, G., Giorgetti, G., Nasi, G. Eur. J. Gastroenterol. Hepatol (2003) [Pubmed]
  45. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. Tursi, A., Brandimarte, G., Giorgetti, G.M. J. Clin. Gastroenterol. (2003) [Pubmed]
  46. Effectiveness of the sorbitol H2 breath test in detecting histological damage among relatives of coeliacs. Tursi, A., Brandimarte, G., Giorgetti, G.M., Inchingolo, C.D. Scand. J. Gastroenterol. (2003) [Pubmed]
  47. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. Tursi, A., Brandimarte, G., Giorgetti, G.M. J. Clin. Gastroenterol. (2003) [Pubmed]
  48. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection. Tursi, A., Brandimarte, G., Giorgetti, G., Modeo, M.E., Gigliobianco, A. Hepatogastroenterology (2002) [Pubmed]
  49. Endoscopic features of celiac disease in adults and their correlation with age, histological damage, and clinical form of the disease. Tursi, A., Brandimarte, G., Giorgetti, G.M., Gigliobianco, A. Endoscopy (2002) [Pubmed]
  50. Sorbitol H2-breath test versus anti-endomysium antibodies to assess histological recovery after gluten-free diet in coeliac disease. Tursi, A., Brandimarte, G., Giorgetti, G.M. Dig. Liver. Dis (2002) [Pubmed]
 
WikiGenes - Universities